Announced
Completed
Financials
Tags
Private
Venture Capital
United States
Friendly
Private Equity
biotechnology
Domestic
Single Bidder
Completed
Acquisition
Minority
Biotechnology
Synopsis
Thomas Tull-backed At One Ventures, a venture capital firm, led a $60m Series A funding round in Colossal Biosciences, a biotechnology company, with participation from Animoca Brands, Breyer Capital, Animal Capital, Bold Capital, First Light Capital Group, Boost VC, Jazz Ventures, Builders VC, Green Sands Equity and Draper Associates. “We’re making the path to de-extinction and species preservation a reality by bringing the planet one step closer to reversing the downward trend of ecosystem degradation and the staggering loss of biodiversity through cutting edge genetic tools,” Ben Lamm, Colossal Biosciences Co-Founder and CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.